Mitochondria in neurodegenerative disorders: Regulation of the redox state and death signaling leading to neuronal death and survival

Journal of Neural Transmission

Volumn 116, Issue 11, 2009, Pages 1371-1381

  Naoi, Makoto ^a   Maruyama, Wakako ^b   Yi, Hong ^a   Inaba, Keiko ^a   Akao, Yukihiro ^a,c   Shamoto Nagai, Masayo ^b  

^a GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c GIFU UNIVERSITY   (Japan)

Author keywords

Apoptosis; MAO inhibitor; Mitochondria; Neuroprotection; Oxidative stress; Redox state

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); DOPAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N PROPARGYLAMINE; NEUROMELANIN; NEUROPROTECTIVE AGENT; NEUROTOXIN; NEUROTROPHIC FACTOR; PROTEIN BCL 2; QUINONE DERIVATIVE; RASAGILINE; REACTIVE OXYGEN METABOLITE; SELEGILINE; UNCLASSIFIED DRUG;

APOPTOSIS; BRAIN MITOCHONDRION; CELL NUCLEUS; CELL SURVIVAL; DEGENERATIVE DISEASE; DISULFIDE BOND; DRUG PROTEIN BINDING; GENE INDUCTION; HUMAN; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL PERMEABILITY; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OUTER MEMBRANE; OXIDATION; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; ENERGY METABOLISM; GLUTATHIONE; HUMANS; MITOCHONDRIA; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NERVE DEGENERATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 70449536507     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-009-0309-7     Document Type: Review

References (97)

1. PM Abou-Sleiman MM Muqit NW Wood 2006 Expanding insights of mitochondrial dysfunction in Parkinson's disease Nature Rev Neurosci 7 207 219 10.1038/nrn1868 1:CAS:528:DC%2BD28Xhs1Gqt70%3D (Pubitemid 43292466)
2. T Adachi C Schöneich RA Cohen 2005 S-Glutathiolation in redox-sensitive signaling Drug Discov Today Dise Mechan 2 39 46 10.1016/j.ddmec.2005.05.022 1:CAS:528:DC%2BD2MXpvFOmu7Y%3D
3. Y Akao W Maruyama S Shimizu H Yi Y Nakagawa M Shamoto-Nagai MBH Youdim Y Tsujimoto M Naoi 2002 Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan J Neurochem 82 913 923 10.1046/j.1471-4159.2002.01047.x 1:CAS:528:DC%2BD38XmsF2hurc%3D 12358797 (Pubitemid 34898843)
4. Y Akao W Maruyama H Yi M Shamoto-Nagai MBH Youdim M Naoi 2002 An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic Bcl-2 in dopaminergic SH-SY5Y cells Neurosci Lett 326 105 108 10.1016/S0304-3940(02)00332-4 1:CAS:528: DC%2BD38XktFKgt7o%3D 12057839 (Pubitemid 34607570)
5. M Alonso M Melani D Converso A Jaitovich C Paz MC Carreras JH Medina JJ Poderoso 2004 Mitochondrial extracellular signal-regulated kinases 1/2 (ERK1/2) are modulated during brain development J Neurochem 89 248 256 10.1111/j.1471-4159.2004.02323.x 1:CAS:528:DC%2BD2cXjtValt7o%3D 15030409
6. B Antonsson F Conti A Ciavatta, et al. 1997 Inhibition of Bax channel-forming activity by Bcl-2 Science 277 370 372 10.1126/science.277.5324. 370 1:CAS:528:DyaK2sXkvVels7s%3D 9219694 (Pubitemid 27450709)
7. MA Applegate KM Humphries LI Szweda 2008 Reversible inhibition of alpha-ketoglutarate dehydrogenase by hydrogen peroxide: glutathionylation and protection of lipoic acid Biochemistry 47 473 478 10.1021/bi7017464 1:CAS:528:DC%2BD2sXhsVehtbbN 18081316
8. O Bar-Am T Amit MBH Youdim 2007 Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostignol, respectively, exert neuroprotective properties in vitro J Neurochem 103 500 508 10.1111/j.1471-4159.2007.04777.x 1:CAS:528:DC%2BD2sXht1KqsLzP 17635668 (Pubitemid 47498024)
9. M Bauer M Meyer L Grimm T Meitinger J Zimmer T Gasser M Ueffing HR Widmer 2000 Nonviral glial cell-derived neurotrophic factor gene transfer enhances survival of cultured dopaminergic neurons and improves their function after transplantation in a rat model of Parkinson's disease Hum Gene Ther 11 1529 1541 10.1089/10430340050083261 1:CAS:528:DC%2BD3cXlt1Gjsbw%3D 10945767 (Pubitemid 30670605)
10. D Ben-Shachar R Zuk H Gazawi P Ljubuncic 2004 Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders Biochem Pharmacol 67 1965 1974 10.1016/j.bcp.2004.02. 015 1:CAS:528:DC%2BD2cXjvVCju7s%3D 15130772 (Pubitemid 38591384)
11. MM Bespalov M Saarma 2007 GDNF family receptor complexes are emerging drug targets Trends Pharmacol Sci 28 68 74 10.1016/j.tips.2006.12.005 1:CAS:528:DC%2BD2sXhtlCmu7g%3D 17218019 (Pubitemid 46161837)
12. F Blandini MT Armentero T Fancellu E Blaugrund G Nappi 2004 Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease Exp Neurol 187 455 459 10.1016/j.expneurol.2004.03.005 1:CAS:528: DC%2BD2cXktV2lsL0%3D 15144871 (Pubitemid 38610291)
13. V Bogaerts J Theuns C van Broeckhoven 2008 Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria? Genes Brain Behav 7 129 151 10.1111/j.1601-183X.2007.00342.x 1:CAS:528:DC%2BD1cXks1Sqtrg%3D 17680806 (Pubitemid 351342198)
14. S Camandola MP Mattson 2007 NF-kB as a therapeutic target in neurodegenerative diseases Expert Opin Ther Targets 11 123 132 10.1517/14728222.11.2.123 1:CAS:528:DC%2BD2sXlt12rtA%3D%3D 17227229 (Pubitemid 46188809)
15. MC Carrillo C Minami K Kitani W Maruyama K Ohashi T Yamamoto M Naoi K Kanai MBH Youdim 2000 Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat Life Sci 67 577 585 10.1016/S0024-3205(00)00643-3 1:CAS:528:DC%2BD3cXksVKjurg%3D 10993123 (Pubitemid 30431547)
16. CL Chen L Zhang A Yeh CA Chen KB Green-Church JL Zweier YR Chen 2007 Site-specific S-glutathiolation of mitochondrial NADH ubiquinone reductase Biochemistry 46 5754 5765 10.1021/bi602580c 1:CAS:528:DC%2BD2sXksVSmt7c%3D 17444656 (Pubitemid 46764124)
17. J Choi HD Rees ST Weintraub AI Levey LS Chin L Li 2005 Oxidative modifications and aggregation of Cu, Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases J Biol Chem 280 11648 11655 10.1074/jbc.M414327200 1:CAS:528:DC%2BD2MXisVyjt7Y%3D 15659387 (Pubitemid 40418479)
18. JV Cross DJ Templeton 2004 Thiol oxidation of cell signaling proteins: controlling an apoptotic equilibrium J Cell Biochem 93 104 111 10.1002/jcb.20202 1:CAS:528:DC%2BD2cXns1Siur0%3D 15352167
19. TM Dawson VL Dawson 2002 Neuroprotective and neurorestorative strategies for Parkinson's disease Nature Neurosci Supp 5 1058 1061 10.1038/nn941 1:CAS:528:DC%2BD38Xpt1entb0%3D (Pubitemid 35247199)
20. MW Dodson M Guo 2008 Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease Curr Opin Neurobiol 17 1 7
21. KL Double D Ben-Shachar MB Youdim L Zecca P Riederer M Gerlach 2002 Influence of neuromelanin on oxidative pathways within the human substantia nigra Neurotoxicol Teratol 24 621 628 10.1016/S0892-0362(02)00218-0 1:CAS:528:DC%2BD38XmsVCit7o%3D 12200193 (Pubitemid 35013523)
22. SD Dyall MT Brown PJ Johnson 2004 Ancient invasions: from endosymbionts to organelles Science 304 253 257 10.1126/science.1094884 1:CAS:528: DC%2BD2cXivV2isbc%3D 15073369 (Pubitemid 38452171)
23. DE Edmondson A Mattevi C Binda M Li F Hubalek 2004 Structure and mechanism of monoamine oxidase Curr Med Chem 11 1983 1993 1:CAS:528: DC%2BD2cXlslWmu7s%3D 15279562
24. E Esposito V Di Matteo G Di Giovanni 2007 Death in the substantia nigra: a motor tragedy Expert Rev Neurother 7 677 697 10.1586/14737175.7.6.677 1:CAS:528:DC%2BD2sXmsFWqsr8%3D 17563251 (Pubitemid 46911617)
25. B Fadeel S Orrenius 2005 Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease J Int Med 258 479 517 10.1111/j.1365-2796.2005.01570.x 1:CAS:528:DC%2BD2MXhtlClurfE (Pubitemid 41705391)
26. SS Gill NK Patel GR Hotton K O'Sullivan R McCarter M Bunnage DJ Brooks CN Svendsen P Heywood 2003 Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease Nat Med 9 589 595 10.1038/nm850 1:CAS:528:DC%2BD3sXjtlamtLw%3D 12669033 (Pubitemid 36597106)
27. D Han R Canali J Garcia R Aguilera TK Gallaher E Cadenas 2005 Sites and mechanisms of aconitase inactivation by peroxynitrite: modulation by citrate and glutathione Biochemistry 44 11986 11996 10.1021/bi0509393 1:CAS:528: DC%2BD2MXotVSltrk%3D 16142896 (Pubitemid 41285696)
28. C Henchcliffe MF Beal 2008 Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis Nat Clin Pract Neurol 4 600 609 10.1038/ncpneuro0924 1:CAS:528:DC%2BD1cXhtlWktbnM 18978800
29. IH Henn L Bouman JS Schlehe, et al. 2007 Parkin mediates neuroprotection through activation of IκB kinase/nuclear factor-κB signaling J Neurosci 27 1868 1878 10.1523/JNEUROSCI.5537-06.2007 1:CAS:528: DC%2BD2sXivV2jtb4%3D 17314283 (Pubitemid 46310318)
30. A Hoffmann TH Leung S Baltimore 2003 Genetic analysis of NF-κB/Rel transcription factors defines functional specificities EMBO J 22 5530 5539 10.1093/emboj/cdg534 1:CAS:528:DC%2BD3sXot1Crurk%3D 14532125 (Pubitemid 37279962)
31. M Hong K Mukhida I Medez 2008 GDNF therapy for Parkinson's disease Expert Rev Neurother 8 1125 1139 10.1586/14737175.8.7.1125 1:CAS:528: DC%2BD1cXnvFShs7s%3D 18590482 (Pubitemid 351962079)
32. E Jacotot KF Ferri C El Hamel, et al. 2001 Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein R and Bcl-2 J Exp Med 193 509 519 10.1084/jem.193.4.509 1:CAS:528:DC%2BD3MXhtlGmtbg%3D 11181702 (Pubitemid 32524481)
33. JH Jang YJ Surh 2004 Bcl-2 attenuation of oxidative cell death is associated with up-regulation of gamma-glutamylcysteine ligase via constitutive NF-κB activation J Biol Chem 279 38779 38786 10.1074/jbc.M406371200 1:CAS:528:DC%2BD2cXnt1yjsrs%3D 15208316 (Pubitemid 39296036)
34. A Kastner EC Hirsch O Lejeune F Javoy-Agid O Rascol Y Agid 1992 Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content? J Neurochem 59 1080 1089 10.1111/j.1471-4159.1992.tb08350.x 1:CAS:528:DyaK38XlsVyms7Y%3D 1494900
35. CM Kearns DM Gash 1995 GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo Brain Res 672 104 111 10.1016/0006-8993(94)01366-P 1:CAS:528:DyaK2MXjs1Ckur0%3D 7749731
36. PM Keeney J Xie RA Capaldi JP Benett Jr 2006 Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled J Neurosci 26 5256 5264 10.1523/JNEUROSCI.0984-06.2006 1:CAS:528:DC%2BD28Xlt1Cisrk%3D 16687518 (Pubitemid 44315308)
37. KW Kinnally B Antonsson 2007 A tale of two mitochondrial channels, MAC and PTP, in apoptosis Apoptosis 12 857 868 10.1007/s10495-007-0722-z 1:CAS:528:DC%2BD2sXksFamsb8%3D 17294079 (Pubitemid 46653291)
38. K Kitani C Minami W Maruyama S Kanai GO Ivy MC Carrillo 2000 Common properties for propargylamines of enhancing superoxide dismutase and catalase activities in the dopaminergic system in the rat: implications for the life prolonging effect of (-)deprenyl J Neural Transm Suppl 60 139 156 11205136
39. G Kroemer L Galluzzi C Brenner 2007 Mitochondrial membrane permeabilization in cell death Physiol Rev 87 99 163 10.1152/physrev.00013.2006 1:CAS:528:DC%2BD2sXitVahu7k%3D 17237344 (Pubitemid 46209992)
40. A Kupsch J Sautter ME Gotz, et al. 2001 Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline J Neural Transm 108 985 1009 10.1007/s007020170018 1:CAS:528:DC%2BD3MXotlGjs7o%3D 11716151
41. JW Langston P Ballard JW Tetrud I Irwin 1983 Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 979 980 10.1126/science.6823561 1:STN:280:DyaL3s7hvF2mtg%3D%3D 6823561
42. X Liu N Yamada W Maruyama T Osawa 2008 Formation of dopamine adducts derived from brain polyunsaturated fatty acids. Mechanism for Parkinson's disease J Biol Chem 283 34887 34895 10.1074/jbc.M805682200 1:CAS:528: DC%2BD1cXhsVGqtrfF 18922792
43. P Maher 2006 Redox control of neural function: Background, mechanisms, and significance Antioxidants Redox Signal 8 1941 1970 10.1089/ars.2006.8.1941 1:CAS:528:DC%2BD28XhtVKntb%2FP
44. S Mandel E Grünblatt P Riederer M Gerlach Y Levites MB Youdim 2003 Neuroprotective strategies in Parkinson's disease: an update on progress CNS Drugs 17 729 762 10.2165/00023210-200317100-00004 1:CAS:528:DC%2BD3sXntl2nsLk%3D 12873156 (Pubitemid 37000010)
45. S Mandel O Weinreb T Amit MB Youdim 2005 Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives Brain Res Brain Res Rev 48 379 387 10.1016/j.brainresrev.2004.12.027 1:CAS:528: DC%2BD2MXjs1Clsr0%3D 15850677 (Pubitemid 40590050)
46. W Mandemakers VA Morais B De Strooper 2007 A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases J Cell Sci 120 1707 1716 10.1242/jcs.03443 1:CAS:528: DC%2BD2sXmvFWrsro%3D 17502481 (Pubitemid 46930408)
47. W Maruyama AA Boulton BA Davis P Dostert M Naoi 2001 Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N- methylpropargylamine J Neural Transm 108 11 24 10.1007/s007020170093 1:CAS:528:DC%2BD3MXivVKku7o%3D 11261742 (Pubitemid 32692610)
48. W Maruyama MB Youdim M Naoi 2001 Antiapoptotic properties of rasagiline, N-propargylamine-1(R)-aminoindan, and its optical (S)-isomer, TV1022 Ann NY Acad Sci 939 320 329 1:CAS:528:DC%2BD3MXlsV2ksL0%3D 11462787
49. W Maruyama Y Akao MB Youdim BA Davis M Naoi 2001 Transfection- enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol J Neurochem 78 727 735 10.1046/j.1471-4159.2001.00448.x 1:CAS:528:DC%2BD3MXmt1egs70%3D 11520893 (Pubitemid 32777974)
50. W Maruyama Y Akao MC Carrillo K Kitani MB Youdim M Naoi 2002 Neuroprotection by propargylamines in Parkinson's disease. Suppression of apoptosis and induction of prosurvival genes Neurotoxicol Teratol 24 675 682 10.1016/S0892-0362(02)00221-0 1:CAS:528:DC%2BD38XmsVCit7c%3D 12200198 (Pubitemid 35013527)
51. W Maruyama T Takahashi M Youdim M Naoi 2002 The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells J Neural Transm 109 467 481 10.1007/s007020200038 1:CAS:528:DC%2BD38XltFagurs%3D 11956966 (Pubitemid 34280405)
52. W Maruyama M Weinstock MB Youdim M Nagai M Naoi 2003 Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor Neurosci Lett 341 233 236 10.1016/S0304-3940(03)00211-8 1:CAS:528:DC%2BD3sXivFCqt7Y%3D 12697291 (Pubitemid 36403771)
53. W Maruyama A Nitta M Shamoto-Nagai Y Hirata Y Akao M Youdim S Furukawa T Nabeshima M Naoi 2004 N-Propargyl-1(R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kB transcription factor Neurochem Int 44 393 400 10.1016/j.neuint.2003.08.005 1:CAS:528:DC%2BD3sXpvVWnsLk%3D 14687604 (Pubitemid 37548404)
54. GP McStay SJ Clarke AP Halestrap 2002 Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore Biochem J 367 541 548 10.1042/BJ20011672 1:CAS:528:DC%2BD38XotVWlt7k%3D 12149099 (Pubitemid 35216831)
55. A Meister 1995 Mitochondrial changes associated with glutathione deficiency Biochim Biophys Acta 1271 35 42 7599223
56. I Mizuta N Ohta K Ohta M Nishimura E Mizuta K Hayashi S Kuno 2000 Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes Biochem Biophys Res Commun 279 751 755 10.1006/bbrc.2000.4037 1:CAS:528:DC%2BD3MXivValug%3D%3D 11162424 (Pubitemid 32042852)
57. M Naoi W Maruyama 2009 Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease Expert Rev Neurother 9 1233 1250 10.1586/ern.09.68 1:CAS:528:DC%2BD1MXpvF2ku70%3D 19673610
58. M Naoi W Maruyama Y Akao H Yi 2002 Dopamine-derived endogenous N-methyl-(R)-salsolinol. Its role in Parkinson's disease Neurotoxicol Teratol 24 579 591 10.1016/S0892-0362(02)00211-8 1:CAS:528:DC%2BD38XmsVCit74%3D 12200189 (Pubitemid 35013519)
59. M Naoi W Maruyama Y Akao H Yi 2002 Mitochondria determine the survival and death in apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, and neuroprotection by propargylamines J Neural Transm 109 607 621 10.1007/s007020200050 1:CAS:528:DC%2BD38XmtVCqsrs%3D 12111453 (Pubitemid 34810759)
60. M Naoi W Maruyama Y Akao H Yi Y Yamaoka 2006 Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection J Neural Transm Suppl 71 67 77 10.1007/978-3-211-33328-0-8 1:CAS:528:DC%2BD28Xht1OltLjE 17447417
61. M Naoi W Maruyama H Yi Y Akao Y Yamaoka M Shamoto-Nagai 2007 Neuroprotection by propargylamines in Parkinson's disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers J Neural Transm Supp 72 121 131 10.1007/978-3-211-73574-9-15 1:CAS:528:DC%2BD2sXhsVKns7nM
62. M Naoi W Maruyama H Yi, et al. 2008 Neuromelanin selectively induces apoptosis in dopaminergic SH-SY5Y cells by deglutathionylation in mitochondria: involvement of protein and melanin component J Neurochem 105 2489 2500 10.1111/j.1471-4159.2008.05329.x 1:CAS:528:DC%2BD1cXnvVWiu7w%3D (Pubitemid 351782270)
63. XM Ou D Lu C Johnson K Chen MBH Youdim G Rajkowska JC Shih 2009 Glycerldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan Neurotoxicol Res 16 148 159 10.1007/s12640-009-9064-7 1:CAS:528: DC%2BD1MXptFCrtrc%3D
64. A Panov S Dikalov N Shalbuyeva G Taylor T Shererr JT Greenamyre 2005 Rotenone model of Parkinson's disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication J Biol Chem 280 42026 42035 10.1074/jbc.M508628200 1:CAS:528:DC%2BD2MXhtlajsrbM 16243845 (Pubitemid 43023171)
65. MA Paz R Flückinger A Boak M Kagan PM Gallop 1991 Specific detection of quinoproteins by redox-cycling staining J Biol Chem 266 689 692 1:CAS:528:DyaK3MXpslWhsw%3D%3D 1702437
66. C Perier J Bove DC Wu, et al. 2007 Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease Proc Natl Acad Sci USA 104 8161 8166 10.1073/pnas.0609874104 1:CAS:528:DC%2BD2sXmtFWgu78%3D 17483459 (Pubitemid 47185892)
67. ND Perkins 2007 Integrating cell-signalling pathways with NF-κB and IKK function Nat Rev Mol Cell Biol 8 49 62 10.1038/nrm2083 1:CAS:528: DC%2BD28XhtlCjt7bK 17183360 (Pubitemid 46012014)
68. S Przedborski K Tieu C Perier N Vila 2004 MPTP as a mitochondrial neurotoxic model of Parkinson's disease J Bioenerg Biomembr 36 375 379 10.1023/B:JOBB.0000041771.66775.d5 1:CAS:528:DC%2BD2cXnsFyjtbc%3D 15377875 (Pubitemid 39619844)
69. S Qanungo DW Starke HV Pai JJ Mieyal A-L Nieminen 2007 Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFκB J Biol Chem 282 18427 18436 10.1074/jbc.M610934200 1:CAS:528:DC%2BD2sXmsVOks70%3D 17468103 (Pubitemid 47100260)
70. R Raddatz A Parini SM Lanier 1995 Imidazoline/guanidinium binding domains on monoamine oxidases J Biol Chem 270 27961 27968 10.1074/jbc.270.46.27961 1:CAS:528:DyaK2MXpsFShu70%3D 7499273
71. NL Reynaert A van der Viliet AS Guala, et al. 2006 Dynamic redox control of NF-κB through glutaredoxin-regulated S-glutathionylation of inhibitory κB kinase β Proc Natl Acad Sci USA 13 13086 13091 10.1073/pnas.0603290103 (Pubitemid 44338920)
72. PF Riederer 2004 Views on neurodegeneration as a basis for neuroprotective strategies Med Sci Monit 10 RA287 RA290 1:CAS:528: DC%2BD2MXls1Ckug%3D%3D
73. P Riederer E Sofic W-D Rausch B Schmidt GP Reynolds K Jellinger MB Youdim 1989 Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains J Neurochem 52 515 520 10.1111/j.1471-4159.1989.tb09150.x 1:CAS:528:DyaL1MXhtFals78%3D 2911028 (Pubitemid 19037617)
74. Y Sagi S Mandel T Amit MB Youdim 2007 Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP induced parkinsonism Neurobiol Dis 25 35 44 10.1016/j.nbd.2006.07.020 1:CAS:528:DC%2BD28Xht1Cls73L 17055733 (Pubitemid 44765215)
75. FQ Schafer GR Beutner 2001 Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple Free Rad Biol Med 30 1191 1212 10.1016/S0891-5849(01)00480-4 1:CAS:528: DC%2BD3MXjsFegt78%3D 11368918 (Pubitemid 32463931)
76. AH Schapira JM Cooper D Dexter JB Clark P Jenner CD Marsden 1990 Mitochondrial complex I deficiency in Parkinson's disease J Neurochem 54 823 827 10.1111/j.1471-4159.1990.tb02325.x 1:CAS:528:DyaK3cXhsFKiur4%3D 2154550
77. PS Schwartz DM Hockenbery 2006 Bcl-2-related survival proteins Cell Death Differ 13 1250 1255 10.1038/sj.cdd.4401982 1:CAS:528:DC%2BD28XmvFaitbs%3D 16763619 (Pubitemid 44057453)
78. I Semkova P Woilz M Schilling J Krieglstein 1996 Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage Eur J Pharmacol 315 19 30 10.1016/S0014-2999(96)00593-6 1:CAS:528:DyaK28XntFWqu7Y%3D 8960860 (Pubitemid 26390945)
79. NA Seniuk JT Henderson WG Tatton JC Roder 1994 Increased CNTF gene expression in process-bearing astrocytes following injury is augmented by R(-)-deprenyl J Neurosci Res 37 278 286 10.1002/jnr.490370213 1:CAS:528:DyaK2cXhvVart7k%3D 8060389
80. JJ Shacka KA Roth 2005 Regulation of neuronal cell death and neurodegeneration by members of the Bcl-2 family: therapeutic implications Curr Drug Targets CNS Neurol Dis 4 25 39 10.2174/1568007053005127 1:CAS:528:DC%2BD2MXhsVKmsbg%3D (Pubitemid 41408406)
81. M Shamoto-Nagai W Maruyama, et al. 2004 Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells J Neural Transm 111 1253 1265 10.1007/s00702-004-0211-2 1:CAS:528:DC%2BD2cXotFCrur0%3D 15480837 (Pubitemid 39468389)
82. M Shamoto-Nagai W Maruyama H Yi Y Akao F Tribl M Gerlach T Osawa P Riederer M Naoi 2006 Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome J Neural Transm 113 633 644 10.1007/s00702-005-0410-5 1:CAS:528: DC%2BD28XjvFGhurs%3D 16362626 (Pubitemid 43673603)
83. L Soane G Fiskum 2005 Inhibition of mitochondrial neural cell death pathways by protein transduction of Bcl-2 family protein J Bioerg Biomembr 37 179 190 10.1007/s10863-005-6590-8 1:CAS:528:DC%2BD2MXhtVWiu7%2FM (Pubitemid 41420473)
84. YP Tang YL Ma CC Chao KY Chen EHY Lee 1998 Enhanced glial cell line-derived neurotrophic factor mRNA expression upon (-)-deprenyl and melatonin treatments J Neurosci Res 53 593 604 10.1002/(SICI)1097-4547(19980901)53: 5<593::AID-JNR9>3.0.CO;2-4 1:STN:280:DyaK1czptlSgsw%3D%3D 9726430 (Pubitemid 28380800)
85. WG Tatton WYL Ju DP Holland C Tai M Kwan 1994 (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis J Neurochem 63 1572 1575 1:CAS:528:DyaK2cXmt1WrsLg%3D 7931312
86. WG Tatton RM Chalmers-Redman WJH Ju M Mammen GW Carlile AW Pong NA Tatton 2002 Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells J Pharmacol Exp Ther 301 753 764 10.1124/jpet.301.2.753 1:CAS:528:DC%2BD38XjtlKisL8%3D 11961082 (Pubitemid 34429993)
87. ER Taylor F Hurrell RJ Shannon TK Lin J Hirst MP Murphy 2003 Reversible glutathionylation of complex I increases mitochondrial superoxide formation J Biol Chem 278 19603 19610 10.1074/jbc.M209359200 1:CAS:528:DC%2BD3sXktVaqsLY%3D 12649289 (Pubitemid 36799143)
88. DM Townsend 2007 S-Glutathionylation Indicator of cell stress and regulator of the unfolded protein response Mol Interv 7 313 324 10.1124/mi.7.6.7 1:CAS:528:DC%2BD1cXitVWisbw%3D 18199853
89. M Vila S Przedborski 2004 Genetic clues to the pathogenesis of Parkinson's disease Nat Med 10 S58 S62 10.1038/nm1068 15272270 (Pubitemid 38901868)
90. M Vila D Ramonet C Perier 2008 Mitochondrial alterations in Parkinson's disease: new clues J Neurochem 107 317 328 10.1111/j.1471-4159.2008.05604.x 1:CAS:528:DC%2BD1cXhtlajtb3J 18680555
91. O Weinreb O Bar-Am T Amit O Chillag-Talmor MB Youdim 2004 Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members FASEB J 18 1471 1473 1:CAS:528:DC%2BD2cXntlKkuro%3D 15247150
92. P Wenzel U Hink M Oelze, et al. 2007 Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance J Biol Chem 282 792 799 10.1074/jbc.M606477200 1:CAS:528:DC%2BD2sXkslCl 17102135 (Pubitemid 47076617)
93. H Yi Y Akao W Maruyama K Chen J Shih M Naoi 2006 Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl-(R)salsolinol, leading to apoptosis in SH-SY5Y cells J Neurochem 96 541 549 10.1111/j.1471-4159.2005.03573.x 1:CAS:528:DC%2BD28XntVShsQ%3D%3D 16336631
94. H Yi W Maruyama Y Akao T Takahashi K Iwasa MBH Youdim M Naoi 2006 N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2 J Neural Transm 113 21 32 10.1007/s00702-005-0299-z 1:CAS:528:DC%2BD2MXhtlCksrfN 15843867 (Pubitemid 41828953)
95. MB Youdim T Amit M Falach-Vogev OB Am W Maruyama M Naoi 2003 The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline Biochem Pharmacol 66 1635 1641 10.1016/S0006-2952(03)00535-5 1:CAS:528:DC%2BD3sXnvVeqsLk%3D 14555244 (Pubitemid 38373356)
96. MBH Youdim D Edmondson KF Tipton 2006 The therapeutic potential of monoamine oxidase inhibitors Nat Rev Neurosi 7 295 309 10.1038/nrn1883 1:CAS:528:DC%2BD28Xis1Gksrs%3D
97. L Zecca H Wilms S Geick, et al. 2008 Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra; implications for Parkinson's disease Acta Neuropathol 116 47 55 10.1007/s00401-008-0361-7 1:CAS:528:DC%2BD1cXosVOjtLg%3D 18343932